The Lab

Reconstitution guides, a growing peptide reference, and bench-ready calculators. For research and educational reference only.

Foundayo gets an EMA green light, but what comes next

Quick answer: On 15 October 2026 EMA's medicines committee (the CHMP) recommended authorising Foundayo (orforglipron) for type 2 diabetes and weight management; the European Commission's decision is a later step.... Read more...
Why GLP-1 peptides degrade and how to stop wasting vials

GLP-1 peptides degrade mainly from heat, light, and freezing, which drive two decay pathways: chemical changes to the molecule and physical clumping (aggregation), and manufacturer labels set finite in-use windows... Read more...
How Long Does Semaglutide Last After Opening at the Bench

An FDA-approved semaglutide pen is labeled for up to 56 days after first use, refrigerated or at room temperature; a lab-reconstituted sample has no such label and needs more conservative... Read more...
Why India's GLP-1 boom could put fakes in your vials

GLP-1 agonists are lab-made research peptides engineered to mimic glucagon-like peptide-1, a hormone that activates a specific receptor on certain cells. Newer variants, like dual agonists, are designed to engage... Read more...
What the tirzepatide sleep apnea trial means for vial storage and handling

Quick answer: SURMOUNT-OSA (Malhotra et al., N Engl J Med 2024) was two phase 3, double-blind, randomized, controlled trials of tirzepatide against placebo in adults with moderate-to-severe obstructive sleep apnea... Read more...
Why stacking GHRP-2 with sermorelin doubles your math

Sermorelin is a lab-made 29-amino-acid fragment of growth hormone releasing hormone (GHRH). GHRP-2 is a synthetic six-amino-acid peptide engineered to mimic ghrelin. In pituitary research models, each engages a separate... Read more...
Why a Cardiac Surgery Peptide Trial Matters at Your Bench

LSALT is a synthetic tripeptide — three amino acids, Met-Arg-Trp (MRW) — not a small molecule. The proposed anti-adhesion mechanism acts at the neutrophil–endothelium interface, a different category from vasodilator... Read more...
Why your GLP-1 vials degrade faster than the data suggests

Multi-agonist GLP-1 research peptides degrade faster than published stability data suggests because their longer, more hydrophobic sequences are prone to aggregation, and routine HPLC testing often misses the truncations and... Read more...
New TB risk data raises the bar on your GLP-1 sourcing

Glucagon-like peptide-1 (GLP-1) receptor agonists are synthetic peptides designed to bind the same receptor as the natural gut hormone GLP-1. New observational research compares tuberculosis diagnosis rates among type 2... Read more...
Why your reconstituted peptides lose potency fast

Reconstituted peptides are research solutions made by mixing lyophilized peptide powders with a liquid diluent such as bacteriostatic water. Once combined, the molecules begin degrading immediately through hydrolysis and oxidation... Read more...
Why your GLP-1 vials are quietly losing potency on the bench

For research and educational reference only. PreppinPeppers sells laboratory hardware and materials (reconstitution pens, cartridges, and bacteriostatic water); it does not sell peptides or any substance for consumption. This is... Read more...
Diluent and Cold Storage Choices That Protect GLP-1 Potency

GLP-1 is a short peptide hormone built from a chain of 30 or 31 amino acids. Like any peptide, its three-dimensional structure is held together by weak chemical bonds that... Read more...
GLP-1 Degradation Pathways: Storage Temps and Timelines

GLP-1 research samples degrade through oxidation, improper pH, freeze-thaw cycles, and adsorption. Learn which storage and reconstitution factors matter most. Read more...
Why the FDA's peptide crackdown matters for your sourcing

"FDA peptide restrictions" is shorthand for tightened enforcement under sections 503A and 503B of the Food, Drug, and Cosmetic Act — the rules that govern which peptides a licensed compounding... Read more...
Why GLP-1 Supply Crunch Matters Even If You're Just Doing Research

GLP-1 supply crunch is straining city budgets nationwide. Find out why mounting demand pressures matter for peptide researchers, not just healthcare patients. Read more...
Why employers are saying no to GLP-1 coverage, and what it means for your research

Employers are increasingly rejecting GLP-1 coverage—learn why cost and policy forces are driving the shift and what it means for lab researchers. Read more...
Why BPC-157 Stays Stable When Other Peptides Degrade

BPC-157 resists degradation that destroys most peptides within hours. Explore the structural reasons behind its exceptional stability for research reference. Read more...
What unauthorized GLP-1 imports mean for your research samples

Unauthorized GLP-1 imports sidestep FDA facility checks and chain-of-custody records, raising real questions about research sample integrity. Read more...
What tripeptides like GHK-Cu do that larger peptides can't

When peptide length drops to three residues, solubility, receptor access, and behavior shift. Compare GHK-Cu and Gly-Pro-Hyp to longer research peptides. Read more...
Tirzepatide vs Semaglutide: What the Head-to-Head Data Shows

GLP-1 receptor agonist research sheds light on peptide stability and degradation pathways—practical context for researchers working with vials at the bench. Read more...
The enzyme quietly destroying your GLP-1 samples

DPP-4 (dipeptidyl peptidase-4) is a serine exopeptidase — an enzyme that works from the free end of a peptide chain rather than cutting in the middle. It recognizes a specific... Read more...
The Alzheimer's plaque review that affects your GLP-1 work

GLP-1 receptor agonists are a class of research peptides - semaglutide is the most familiar example - originally studied for type 2 diabetes and weight regulation. Tirzepatide is a related... Read more...
Why your peptide's charge quietly controls its shelf life

A peptide's net electrical charge, set by its amino acid composition, is the chemical property that determines how quickly it releases from a charged gelatin gel and how strongly it... Read more...
Why BofA's $250M GLP-1 bill matters for your vials

Bank of America's $250M+ employee benefits bill for GLP-1 drugs is a publicly reported figure that functions as a market signal for demand, manufacturing capacity, and supply pressure on the... Read more...
Get more of The Lab in your Google results